Medtronic stock holds near USD 92 as MiniMed split advances

Published on 09/22/2026 at 11:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic stock traded at USD 91.65 on September 21, 2026, with a USD 117.35 billion market cap. Needham kept a USD 114 target.

Isometrische 3D-Grafik der medizintechnischen Wertschöpfungskette von Rohstoff bis Klinik — Medtronic plc (ISIN IE00BTN1Y115) isometrische Grafik visualisiert Wertschöpfungskette von Rohstoff bis Krankenhaus schematisch, Illustration mit AI erstellt.

Medtronic plc (IE00BTN1Y115) traded at USD 91.65 on the NYSE on September 21, 2026, while the company advanced plans to separate its MiniMed diabetes business. The quote sat within a 52-week range of USD 73.31 to USD 106.33, giving the stock a concrete valuation marker for the next phase of the restructuring.

MiniMed separation drives the story

According to Stock Titan on September 21, 2026, Medtronic outlined the planned MiniMed split-off in a business-combination communication. The filing gives the diabetes operation a separate strategic path while leaving investors to assess how the transaction could change the remaining medical-device portfolio.

The market data add scale to that decision. Medtronic had a market capitalization of USD 117.35 billion and trading volume of 7.31 million shares on September 21, 2026. Volume was below the cited average daily volume of 8.70 million shares, so the restructuring headline was not accompanied by an unusually high trading turnover.

Needham keeps USD 114 target

According to the Medtronic market overview on Robinhood on September 22, 2026, Needham analyst Michael Matson reaffirmed a Buy rating and kept the price target at USD 114 after the USD 700 million Cornerstone Robotics deal. The unchanged target stands USD 22.35 above the September 21 closing price, or 24.4 percent higher based on those two quoted levels.

The comparison matters because it separates the analyst case from the immediate trading picture. The stock remained USD 14.68 below its 52-week high of USD 106.33 and USD 18.34 above its 52-week low of USD 73.31 on September 21, 2026. The range therefore places the shares closer to the upper half of their annual band, but not at the yearly peak.

Next earnings date is November 17

Zacks listed November 17, 2026 as Medtronic's next expected earnings release date. Its calendar also reported earnings of USD 1.45 per share for the last quarter, above the USD 1.39 consensus estimate, a USD 0.06 per-share beat that provides a quantified operating reference alongside the portfolio reshaping.

Medtronic stock closed at USD 91.65 on the NYSE on September 21, 2026. The same session covered USD 91.50 to USD 92.73, while the 52-week range remained USD 73.31 to USD 106.33.